NCI, National Clinical Trials Network Lead Academic Participating Site (LAPS) UG1

NCI，国家临床试验网络牵头学术参与站点 (LAPS) UG1

• 批准号: 10115645
• 负责人: STEVEN R ALBERTS
• 金额: $ 108.41万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-04-12 至 2025-02-28
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10115645
• 关键词: Advocate; American College of Radiology Imaging Network; Applications Grants; Arizona; Awareness; Cancer Patient; Cancer Science; Catchment Area; Clinic; Clinical Research; Clinical Trials; Clinical Trials Network; Collaborations; Conduct Clinical Trials; Data; Development; Discipline; Disease; Eastern Cooperative Oncology Group; Ensure; Ethnic Origin; Florida; Focus Groups; Funding; Grant; Gynecologic Oncology Group; Individual; Institution; International; Journals; Lead; Leadership; Malignant Neoplasms; Mayo Clinic Cancer Center; Mentors; Methods; Minnesota; Minority Enrollment; Minority Groups; Monitor; National Clinical Trials Network; National Surgical Adjuvant Breast and Bowel Project; North Central Cancer Treatment Group; Outcome; Participant; Patient Care; Patients; Physicians; Publications; Publishing; Research; Research Personnel; Role; Rural; Rural Population; Site; Special Population; Strategic Planning; Underserved Population; Universities; cancer care; cancer clinical trial; cancer risk; clinical trial enrollment; cognitive computing; health disparity; innovation; meetings; member; programs; recruit; socioeconomics; success

PROJECT SUMMARY As reflected in this application, Mayo Clinic has a long tradition of clinical research and has been a supporter and active participant in the National Clinical Trials Network (NCTN). Support of the NCTN includes formation of one of the founding organizations (North Central Cancer Treatment Group, now Alliance), Sustained leadership roles in the NCTN and in clinical trials, as well as active supporters of clinical trials. Multiple Mayo Clinic staff continue in current leadership roles within the NCTN or NCI sponsored activities related to the NCTN. Mayo Clinic remains committed to making NCTN trials a prominent part of its portfolio of clinical trials for cancer patients or patients at-risk for cancer. This commitment is reflected in the prioritization of NCTN trials over many other trials, the level of accrual to NCTN trials, further refinements to the activation and monitoring of progress of NCTN trials to ensure their success, the continued leadership role of Mayo Clinic physicians in the NCTN member organizations, and an on-going commitment of the MCCC to support this activity. Mayo Clinic physicians and researchers continue to have an active role in not only patient accrual to NCTN clinical trials, but to leadership in developing and leading trials. Mayo Clinic researchers also continue to be active in presenting the results of these trials at national and international meetings and high-impact journals, as described within the current grant application. Mayo Clinic researchers have continued to be active in performing subsequent analyses of the collected data, and meaningful use of the biospecimens collected from the trials to transform the science of cancer care. Mayo Clinic has also continued to focus on the development of junior investigators in the NCTN to ensure the continued active support of NCTN member organizations and the success of NCTN clinical research. Finally, Mayo Clinic is committed to making clinical trials available to all patients, regardless of their racial, ethnicity, or socioeconomic background.

项目摘要 正如本应用程序所反映的那样，梅奥诊所具有悠久的临床研究传统，并且一直是支持者 并积极参与国家临床试验网络（NCTN）。 NCTN的支持包括编队 一个创始组织之一（北中央癌症治疗小组，现为联盟）持续 在NCTN和临床试验中的领导角色以及临床试验的积极支持者。多个蛋黄酱 诊所工作人员继续担当NCTN或NCI赞助的活动中的当前领导角色 NCTN。 Mayo Clinic仍致力于使NCTN试验成为其临床试验组合的重要组成部分 适用于癌症患者或癌症患者。这种承诺反映在NCTN的优先级中 在许多其他试验中的试验，NCTN试验的应计水平，进一步的激活和进一步改进 监测NCTN试验的进度以确保其成功，Mayo Clinic的持续领导角色 NCTN成员组织中的医师，以及MCCC的持续承诺支持这一点 活动。梅奥诊所的医生和研究人员不仅在患者应计的患者中发挥积极作用 NCTN临床试验，但要领导发展和领导试验。梅奥诊所研究人员也继续 积极在国家和国际会议上介绍这些试验的结果以及高影响力 期刊，如当前赠款申请中所述。梅奥诊所的研究人员继续活跃 在进行收集数据的后续分析以及对收集的生物测量的有意义的使用时 从试验转变癌症护理科学。梅奥诊所还继续关注 在NCTN中开发初级研究人员，以确保NCTN成员的持续积极支持 组织和NCTN临床研究的成功。最后，梅奥诊所致力于进行临床 所有患者都可以接受试验，无论其种族，种族或社会经济背景如何。